Evidence map›Paper›PMID 39948640›Full record

ArticleBiomarker research2025

Correction: MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer.

Xin-Yi Sui, Shuo-Wen Cao, Xiao-Qing Song, Xi-Yu Liu, Chao Chen, Qingya Yan, Zhi-Qing Wang, Wen-Juan Zhang, Lin-Xiaoxi Ma, Xi Jin and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomarker research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Xin-Yi Sui *Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Shuo-Wen Cao *Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Xiao-Qing Song *Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Xi-Yu Liu *Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Chao ChenDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Qingya YanSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Zhi-Qing WangDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Wen-Juan ZhangDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Lin-Xiaoxi MaDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Xi JinDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Ding MaDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Yi XiaoDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Song-Yang WuDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Ying XuDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhi-Ming ShaoDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. zhi_ming_shao@163.com.
Lei FanDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. drfanlei@outlook.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39948640
PMCPMC11827472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.